Carestream Molecular Imaging's Latest Gel Documentation System

Carestream Health, Inc.Performing everyday in vitro scientific imaging applications is fast and easy with Carestream Molecular Imaging's next-generation, fully automated gel imaging system. Featuring a redesigned user interface, improved look-and-feel and major productivity enhancements, including auto-focus and auto-exposure, the Gel Logic 212 PRO Imaging System enables researchers to capture perfectly exposed images in just a few clicks.

The new system is ideal for documenting and analysing fluorescent, colorimetric data in sample formats such as gels (e.g., DNA, Coomassie and silver stain), membranes and 96 well plates.

"The user-friendly, intuitive software of the Gel Logic 212 PRO makes it much easier to use than other systems I have experienced," said Brian Foster, University of Washington School of Dentistry. "I was most impressed with the flexibility of the illumination sources, which allowed us to extend the use of the system to additional assays in our lab."

The Gel Logic 212 PRO Imaging System is designed for medium-to-large labs in which workflow, high-sample throughput, safety and high-quality image analysis are critical. Key features and benefits include:

  • True 12-bit data capture - Scientific-grade, 1.4 million-pixel CCD camera can accumulate up to 12 bits of data, resulting in more detail and higher accuracy. Researchers can detect and quantify very dim as well as very bright signals (e.g. bands) in the same image.
  • Auto-focus and easy-illumination - Focuses perfectly on samples with exposure levels automatically adjusted to optimise image quality without saturations. Lighting options are motorised, enabling illumination to be quickly adjusted via virtual controls.
  • Motorised lens with 6x zoom - An 8-48mm motorised lens combines with a 1.4 mega-pixel CCD to offer automated focus and excellent resolution for small sample imaging.
  • Available white light trans-illuminator - LED-based white light source offers high uniformity and strong adjustable illuminations of samples.

"We redesigned our core gel documentation system from the ground up, with the aim of making fundamental imaging applications that researchers perform every day easier and more reliable," said Craig Smith, Global Product Manager, In Vitro Systems, Carestream Molecular Imaging. "It delivers superb image quality, high performance and ease-of-use not previously seen in this class of gel documentation systems-all at an affordable price."

The system will also be upgradeable for imaging a wider array of samples including chemiluminescence, fluorescence, and chromogenic gels, blots, and plates. All Carestream Molecular Imaging Gel Logic systems ship with Carestream Molecular Imaging Software to optimise performance and quantitative analysis capabilities. For more information including a full list of features and benefits, visit www.carestreamhealth.com/gel-logic-systems.html.

About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit http://mi.carestreamhealth.com.

Related news articles:

About Carestream Health, Inc.
Formed in 2007, Carestream Health, Inc., is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for the life science research and drug discovery/development market segments; and X-ray film and digital X-ray products for the non-destructive testing market. For more information about the company's broad portfolio of products, solutions and services, please contact your Carestream Health representative or visit www.carestreamhealth.com.

CARESTREAM is a trademark of Carestream Health, Inc.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...